DK0655926T3 - Ny sonde til tumordiagnose eller tumorterapi - Google Patents
Ny sonde til tumordiagnose eller tumorterapiInfo
- Publication number
- DK0655926T3 DK0655926T3 DK93917719T DK93917719T DK0655926T3 DK 0655926 T3 DK0655926 T3 DK 0655926T3 DK 93917719 T DK93917719 T DK 93917719T DK 93917719 T DK93917719 T DK 93917719T DK 0655926 T3 DK0655926 T3 DK 0655926T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- tumor
- diagnosis
- therapy
- new probe
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4225569A DE4225569C2 (de) | 1992-08-03 | 1992-08-03 | Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie |
PCT/EP1993/002051 WO1994003196A1 (de) | 1992-08-03 | 1993-08-02 | Neue sonde zur tumordiagnostik oder tumortherapie |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0655926T3 true DK0655926T3 (da) | 1998-09-21 |
Family
ID=6464707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93917719T DK0655926T3 (da) | 1992-08-03 | 1993-08-02 | Ny sonde til tumordiagnose eller tumorterapi |
Country Status (10)
Country | Link |
---|---|
US (1) | US5747250A (da) |
EP (1) | EP0655926B1 (da) |
JP (1) | JPH07509477A (da) |
AT (1) | ATE162721T1 (da) |
CA (1) | CA2141678A1 (da) |
DE (2) | DE4225569C2 (da) |
DK (1) | DK0655926T3 (da) |
ES (1) | ES2114615T3 (da) |
HK (1) | HK1002531A1 (da) |
WO (1) | WO1994003196A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028184A (en) * | 1996-12-31 | 2000-02-22 | Max-Plank-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Pax6 and Pax4 nucleic acid mixtures |
DE19605105A1 (de) | 1996-02-12 | 1997-08-14 | Gsf Forschungszentrum Umwelt | Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen |
EP1288311A3 (en) * | 1996-12-31 | 2004-09-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells |
ATE310814T1 (de) * | 1996-12-31 | 2005-12-15 | Neues verfahren zur überprüfung des differenzierungszustands pankreatischer zellen eines säugetiers | |
GB9811598D0 (en) * | 1998-05-30 | 1998-07-29 | Imp College Innovations Ltd | Diagnosis and treatment of cancer |
GB9903841D0 (en) | 1999-02-20 | 1999-04-14 | Imp College Innovations Ltd | Diagnosis and treatment of cancer |
WO2001046405A2 (en) * | 1999-12-22 | 2001-06-28 | Mcgill University | Modulation of pax-2 for controlled apoptosis or survival of cells |
WO2001052789A2 (en) | 2000-01-20 | 2001-07-26 | The Brigham And Women's Hospital, Inc. | PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
CN1320634A (zh) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | 一种新的多肽——人含配对盒结构域的蛋白20和编码这种多肽的多核苷酸 |
CN1320616A (zh) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | 一种新的多肽——人Pax蛋白17和编码这种多肽的多核苷酸 |
CN1321681A (zh) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | 一种新的多肽——人Pax蛋白11.3和编码这种多肽的多核苷酸 |
US7601696B1 (en) | 2003-08-22 | 2009-10-13 | University Of South Florida | Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
KR101088885B1 (ko) * | 2008-12-23 | 2011-12-07 | 연세대학교 산학협력단 | 바이오프로브, 그 제조방법, 상기를 사용한 분석 장치 및 분석 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639532B2 (en) * | 1989-12-27 | 1993-07-29 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Diagnostic probe for detecting human stomach cancer |
AU660660B2 (en) * | 1991-02-08 | 1995-07-06 | Roussel-Uclaf | Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
-
1992
- 1992-08-03 DE DE4225569A patent/DE4225569C2/de not_active Expired - Fee Related
-
1993
- 1993-08-02 JP JP6505003A patent/JPH07509477A/ja active Pending
- 1993-08-02 DK DK93917719T patent/DK0655926T3/da active
- 1993-08-02 CA CA002141678A patent/CA2141678A1/en not_active Abandoned
- 1993-08-02 WO PCT/EP1993/002051 patent/WO1994003196A1/de active IP Right Grant
- 1993-08-02 EP EP93917719A patent/EP0655926B1/de not_active Expired - Lifetime
- 1993-08-02 AT AT93917719T patent/ATE162721T1/de not_active IP Right Cessation
- 1993-08-02 US US08/381,841 patent/US5747250A/en not_active Expired - Lifetime
- 1993-08-02 ES ES93917719T patent/ES2114615T3/es not_active Expired - Lifetime
- 1993-08-02 DE DE59308082T patent/DE59308082D1/de not_active Expired - Fee Related
-
1998
- 1998-02-25 HK HK98101460A patent/HK1002531A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1994003196A1 (de) | 1994-02-17 |
DE4225569A1 (de) | 1994-02-10 |
EP0655926A1 (de) | 1995-06-07 |
US5747250A (en) | 1998-05-05 |
HK1002531A1 (en) | 1998-08-28 |
EP0655926B1 (de) | 1998-01-28 |
CA2141678A1 (en) | 1994-02-17 |
ES2114615T3 (es) | 1998-06-01 |
JPH07509477A (ja) | 1995-10-19 |
DE59308082D1 (de) | 1998-03-05 |
DE4225569C2 (de) | 1996-04-25 |
ATE162721T1 (de) | 1998-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0655926T3 (da) | Ny sonde til tumordiagnose eller tumorterapi | |
Hautmann et al. | A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements | |
Mason et al. | Corticospinal neurons up‐regulate a range of growth‐associated genes following intracortical, but not spinal, axotomy | |
BR9914643A (pt) | Vetores adeno-associados para expressão dofator viii por células alvo | |
DE69433626D1 (de) | N-2 substituierte purine | |
NO981944D0 (no) | Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav | |
DE69329240D1 (de) | 17-ether und thioether von 4-aza-steroiden | |
ATE459715T1 (de) | Regulierte gene und ihre verwendungen | |
EP1410804A4 (en) | CANCER VACCINE WITH CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GEN WT1 PRODUCT AND CATIONIC LIPOSOME | |
DK1011723T3 (da) | 88KDA tumorgen vækstfaktor og antagonister | |
ATE478686T1 (de) | Medikamente für massive tumore, welche inhibitoren der expression des wilms' tumorgens enthalten | |
ATE188257T1 (de) | Benutzung von reagenzien abgeleitet vom menschlichen metastase unterdrückungs gen kai1 in diagnostischen und gen-terapeutischen verfahren | |
BR9813917A (pt) | Vetores de expressão induzìveis hipertérmicospara terapia de genetica e métodos de uso dos mesmos | |
WO2001044282A3 (en) | Bcl-g polypeptides, encoding nucleic acids and methods of use | |
NZ504445A (en) | Nucleic acid sequences of genes of the high mobility group proteins and their use in treating tumours, vascular disorders and as a contraceptive | |
ATE297464T1 (de) | Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz | |
ATE204021T1 (de) | Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase | |
HUP0201868A2 (en) | Antisense therapy for hormone-regulated tumors | |
BR0017197A (pt) | Sequência de ácido nucleico, sequência de aminoácido, vetor de clonagem replicativo, célula hospedeira isolada vetor de expressão, métodos para testar uma substância como um agente terapêutico para modulação óssea em um hospedeiro, para identificar uma molécula e uma proteìna candidata envolvidas na modulação óssea, para testar quanto a atividade de hbm, para desenvolvimento farmacêutico para o tratamento de distúrbios do desenvolvimento ósseo, para tratar um distúrbio do desenvolvimento ósseo em um animal, para alterar o desenvolvimento ósseo em um hospedeiro, para tratar a osteoporose, para avaliar diagnóstico para uma predisposição genética a um distúrbio do desenvolvimento ósseo, para identificar uma predisposição genética para distúrbios do desenvolvimento ósseo, para expressar a proteìna de hbm em tecido ósseo, para amplificar um polimorfismo de nucleotìdeo, para identificar um elemento regulador de um gene de hbm e para modular densidade óssea em um paciente, ensaio de diagnóstico para distúrbios do desenvolvimento ósseo, cromossoma artificial bacteriano, segmento de ácido nucleico isolado, ácido nucleico, e, polipeptìdeo. | |
ATE314481T1 (de) | Promotor des transaldolase-genes von k.lactis und dessen verwendung | |
DE69332375T2 (de) | Hundecoronavirus s gen und verwendung davon | |
BR9306663A (pt) | Regiões antigênicas de complexos de partículas liberadas por tumores (TLP) e anticorpos contra os mesmos | |
Batsakis et al. | Iatrogenic aberrations of serum enzyme activity | |
US6844326B2 (en) | Treatment of alopecia | |
ITMI20030860A1 (it) | Metodo per l'inibizione selettiva del gene n-myc |